Cohen Amir 4

What Happened

• Amir Cohen, Chief Accounting Officer of Strata Critical Medical (SRTA), sold a total of 50,875 shares in two open-market transactions. On 2026-05-21 he sold 10,300 shares at $5.79 each for $59,637; on 2026-05-22 he sold 40,575 shares at a weighted average price of $5.91 for $239,798. Total proceeds were roughly $299,435. These were sales (not purchases), which are often routine dispositions rather than affirmative bullish purchases.

Key Details

• Transaction dates and prices:
  • 2026-05-21: 10,300 shares at $5.79 — proceeds $59,637.
  • 2026-05-22: 40,575 shares at a weighted average $5.91 — proceeds $239,798; per footnote this block was sold in multiple trades at prices ranging $5.81–$6.02.
• Plan/footnotes: Sales were made pursuant to a Rule 10b5-1 trading plan adopted by Cohen on December 10, 2025 (per footnote).
• Shares owned after transaction: Not specified in the information provided in your summary.
• Filing timeliness: The Form 4 was filed on 2026-05-26. The 2026-05-21 sale appears to have been reported one business day late (deadline would generally be 2026-05-25); the 2026-05-22 sale was timely reported.

Context

• These were open-market sales executed under a pre-established 10b5-1 plan, which typically schedules trades and can reduce the implication that the insider traded on material nonpublic information. Sales do not necessarily indicate a change in conviction about the company; purchases are generally considered more informative about insider sentiment.